Covalon Technologies Ltd.

TSXV:COV Stock Report

Market Cap: CA$59.9m

Covalon Technologies Future Growth

Future criteria checks 4/6

Covalon Technologies is forecast to grow earnings and revenue by 24.8% and 8.7% per annum respectively. EPS is expected to grow by 23.8% per annum. Return on equity is forecast to be 12% in 3 years.

Key information

24.8%

Earnings growth rate

23.78%

EPS growth rate

Biotechs earnings growth-10.7%
Revenue growth rate8.7%
Future return on equity12.00%
Analyst coverage

Low

Last updated21 May 2026

Recent future growth updates

Recent updates

Analysis Article • Aug 20

Covalon Technologies Ltd.'s (CVE:COV) Popularity With Investors Is Under Threat From Overpricing

TSXV:COV 1 Year Share Price vs Fair Value Explore Covalon Technologies's Fair Values from the Community and select...
Analysis Article • Feb 26

Some Shareholders Feeling Restless Over Covalon Technologies Ltd.'s (CVE:COV) P/S Ratio

It's not a stretch to say that Covalon Technologies Ltd.'s ( CVE:COV ) price-to-sales (or "P/S") ratio of 2.1x seems...
Analysis Article • Nov 17

Subdued Growth No Barrier To Covalon Technologies Ltd. (CVE:COV) With Shares Advancing 29%

Covalon Technologies Ltd. ( CVE:COV ) shares have continued their recent momentum with a 29% gain in the last month...
Analysis Article • Aug 18

Covalon Technologies Ltd.'s (CVE:COV) 25% Share Price Surge Not Quite Adding Up

Despite an already strong run, Covalon Technologies Ltd. ( CVE:COV ) shares have been powering on, with a gain of 25...
Analysis Article • Aug 10

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Analysis Article • Jun 16

Optimistic Investors Push Covalon Technologies Ltd. (CVE:COV) Shares Up 83% But Growth Is Lacking

Covalon Technologies Ltd. ( CVE:COV ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • May 01

Covalon Technologies (CVE:COV) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Analysis Article • Feb 17

Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Covalon Technologies Ltd. ( CVE:COV ) shares have continued their recent momentum with a 25% gain in the last month...
Analysis Article • Dec 22

Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

With a price-to-sales (or "P/S") ratio of 1.2x Covalon Technologies Ltd. ( CVE:COV ) may be sending bullish signals at...
Analysis Article • Sep 02

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article • May 26

We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Apr 29

Is Covalon Technologies (CVE:COV) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Dec 29

Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Earnings and Revenue Growth Forecasts

TSXV:COV - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2028435N/A51
9/30/2027404N/A41
9/30/2026353N/A61
3/31/202633256N/A
12/31/202532178N/A
9/30/202533212N/A
6/30/202533245N/A
3/31/202534455N/A
12/31/202435534N/A
9/30/202431333N/A
6/30/202429-111N/A
3/31/202426-3-3-2N/A
12/31/202325-5-4-3N/A
9/30/202327-4-5-3N/A
6/30/202325-6-6-5N/A
3/31/202323-7-9-8N/A
12/31/202219-9-10-8N/A
9/30/202218-9-9-8N/A
6/30/202219-4-8-8N/A
3/31/202221-2-4-3N/A
12/31/202122000N/A
9/30/202120000N/A
6/30/20217-411N/A
3/31/20217-411N/A
12/31/20208-800N/A
9/30/202014-8-4-4N/A
6/30/202026-8-3-3N/A
3/31/202027-12-4-4N/A
12/31/201935-8N/A-4N/A
9/30/201934-9N/A-3N/A
6/30/201934-6N/A-2N/A
3/31/201935-1N/A-2N/A
12/31/201828-1N/A-4N/A
9/30/2018272N/A-1N/A
6/30/2018303N/A-1N/A
3/31/2018281N/A-1N/A
12/31/2017282N/A0N/A
9/30/2017272N/A0N/A
6/30/201718-1N/A-2N/A
3/31/201715-1N/A-1N/A
12/31/201610-3N/A-1N/A
9/30/20167-3N/A-1N/A
6/30/20168-2N/A-3N/A
3/31/20167-2N/A-3N/A
12/31/201590N/A-3N/A
9/30/20158-1N/A-2N/A
6/30/20157-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: COV's forecast earnings growth (24.8% per year) is above the savings rate (3%).

Earnings vs Market: COV's earnings (24.8% per year) are forecast to grow faster than the Canadian market (10.6% per year).

High Growth Earnings: COV's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: COV's revenue (8.7% per year) is forecast to grow faster than the Canadian market (4.7% per year).

High Growth Revenue: COV's revenue (8.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: COV's Return on Equity is forecast to be low in 3 years time (12%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/15 12:14
End of Day Share Price 2026/06/15 00:00
Earnings2026/03/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Covalon Technologies Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andre UddinResearch Capital Corporation